LHC Stock Overview
Operates as a private healthcare company in Southern Africa. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
No risks detected for LHC from our risk checks.
Life Healthcare Group Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R17.17 |
| 52 Week High | R19.25 |
| 52 Week Low | R9.93 |
| Beta | 0.27 |
| 11 Month Change | 0.76% |
| 3 Month Change | 22.12% |
| 1 Year Change | -4.98% |
| 33 Year Change | -25.38% |
| 5 Year Change | -30.93% |
| Change since IPO | 27.19% |
Recent News & Updates
Recent updates
Here's What's Concerning About Life Healthcare Group Holdings' (JSE:LHC) Returns On Capital
Aug 05
Life Healthcare Group Holdings (JSE:LHC) Is Increasing Its Dividend To ZAR0.17
May 30Life Healthcare Group Holdings (JSE:LHC) Could Be Struggling To Allocate Capital
Apr 20Is Life Healthcare Group Holdings (JSE:LHC) Using Too Much Debt?
Mar 18Life Healthcare Group Holdings (JSE:LHC) Will Want To Turn Around Its Return Trends
Dec 24We Think That There Are More Issues For Life Healthcare Group Holdings (JSE:LHC) Than Just Sluggish Earnings
Nov 24Life Healthcare Group Holdings' (JSE:LHC) Dividend Will Be ZAR0.25
Nov 23An Intrinsic Calculation For Life Healthcare Group Holdings Limited (JSE:LHC) Suggests It's 49% Undervalued
Sep 14Is Life Healthcare Group Holdings (JSE:LHC) Using Too Much Debt?
Aug 15Returns On Capital Signal Tricky Times Ahead For Life Healthcare Group Holdings (JSE:LHC)
Jul 31Are Investors Undervaluing Life Healthcare Group Holdings Limited (JSE:LHC) By 44%?
May 19Be Wary Of Life Healthcare Group Holdings (JSE:LHC) And Its Returns On Capital
Apr 28An Intrinsic Calculation For Life Healthcare Group Holdings Limited (JSE:LHC) Suggests It's 30% Undervalued
Feb 08There Are Reasons To Feel Uneasy About Life Healthcare Group Holdings' (JSE:LHC) Returns On Capital
Jan 25With Life Healthcare Group Holdings Limited (JSE:LHC) It Looks Like You'll Get What You Pay For
Jan 08Does Life Healthcare Group Holdings (JSE:LHC) Have A Healthy Balance Sheet?
Nov 28Are Investors Undervaluing Life Healthcare Group Holdings Limited (JSE:LHC) By 24%?
Oct 19Life Healthcare Group Holdings (JSE:LHC) Is Reinvesting At Lower Rates Of Return
Aug 16We Think Life Healthcare Group Holdings (JSE:LHC) Is Taking Some Risk With Its Debt
Jul 20Capital Allocation Trends At Life Healthcare Group Holdings (JSE:LHC) Aren't Ideal
May 14How Many Life Healthcare Group Holdings Limited (JSE:LHC) Shares Did Insiders Buy, In The Last Year?
Mar 21Shareholder Returns
| LHC | ZA Healthcare | ZA Market | |
|---|---|---|---|
| 7D | 2.3% | 1.6% | 1.7% |
| 1Y | -5.0% | 30.8% | 15.6% |
Return vs Industry: LHC underperformed the ZA Healthcare industry which returned 29.7% over the past year.
Return vs Market: LHC underperformed the ZA Market which returned 15.2% over the past year.
Price Volatility
| LHC volatility | |
|---|---|
| LHC Average Weekly Movement | 4.1% |
| Healthcare Industry Average Movement | 4.1% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in ZA Market | 9.5% |
| 10% least volatile stocks in ZA Market | 2.6% |
Stable Share Price: LHC has not had significant price volatility in the past 3 months compared to the ZA market.
Volatility Over Time: LHC's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | n/a | Peter Wharton-Hood | www.lifehealthcare.co.za |
Life Healthcare Group Holdings Limited, together with its subsidiaries, operates as a private healthcare company in Southern Africa. It also operates as a research and development pharmaceutical company in the United Kingdom, Europe, the United States, and internationally. The company operates acute hospitals.
Life Healthcare Group Holdings Limited Fundamentals Summary
| LHC fundamental statistics | |
|---|---|
| Market cap | R24.73b |
| Earnings (TTM) | R1.41b |
| Revenue (TTM) | R23.76b |
17.5x
P/E Ratio1.0x
P/S RatioIs LHC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LHC income statement (TTM) | |
|---|---|
| Revenue | R23.76b |
| Cost of Revenue | R17.13b |
| Gross Profit | R6.63b |
| Other Expenses | R5.22b |
| Earnings | R1.41b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Nov 26, 2024
| Earnings per share (EPS) | 0.98 |
| Gross Margin | 27.89% |
| Net Profit Margin | 5.93% |
| Debt/Equity Ratio | 33.1% |
How did LHC perform over the long term?
See historical performance and comparison